Advertisement

Pharmacy

There are a few pieces of good news that can be derived from Pfizer's Nov. 9 announcement that interim analysis of its COVID-19 vaccine trial revealed the candidate can prevent more than 90 percent of infections, healthcare officials say.

Advertisement

The FDA is requiring the teams who run clinical trials for new treatments and medical products to ensure greater enrollment for underrepresented groups so that the resulting products do not exacerbate existing health disparities, the agency said in final guidance…

Advertisement